Respond to EMA and FDA consultations by Monday
We urgently need you to respond to two important consultations to defend independent analyses.
Tell the EMA not to censor independent analyses
In Europe, the medicines regulator wants the right to censor analyses of side effects data that it disagrees with. The European Medicines Agency (EMA) is consulting on updates to its EudraVigilance access policy. EudraVigilance is the […]